Document Detail


Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study.
MedLine Citation:
PMID:  3928727     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ventricular tachycardia induced by programmed electrical stimulation during amiodarone therapy often does not preclude a good clinical response. The purpose of this study was to determine whether use of discriminant analysis could distinguish patients who remained asymptomatic from those who subsequently developed symptomatic ventricular tachycardia or cardiac arrest. Studies were performed in 37 patients with sustained ventricular tachycardia who still had ventricular tachycardia induced during programmed electrical stimulation during amiodarone therapy. The mean follow-up time was 14.1 +/- 1.3 months (+/- SEM). Twenty-three patients remained asymptomatic, whereas 14 patients had symptomatic recurrence of their ventricular tachycardia. In patients with recurrence of arrhythmia compared with asymptomatic patients, administration of amiodarone caused a longer ventricular effective refractory period (296 +/- 8 versus 271 +/- 7 ms, p less than 0.05) and a greater change in corrected QT [QTc] interval (90 +/- 18 versus 44 +/- 9 ms, p less than 0.02), but no difference in the decrease in premature ventricular complexes after treatment with amiodarone. During amiodarone therapy, nonbundle branch reentrant repetitive ventricular responses were induced by a single ventricular extrastimulus during sinus rhythm in 9 of 14 patients with recurrent arrhythmias compared with 2 of 21 asymptomatic patients (p = 0.001). Also, less aggressive pacing techniques were required to induce ventricular tachycardia in 9 of 14 symptomatic patients compared with 4 of 23 asymptomatic patients (p less than 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
G V Naccarelli; N S Fineberg; D P Zipes; J J Heger; G Duncan; E N Prystowsky
Related Documents :
11210997 - Observations on recurrent syncope and presyncope in 641 patients.
19359057 - Effect of cardiac resynchronization therapy on the incidence of electrical storm.
6403267 - Chronic tocainide therapy for refractory high-grade ventricular arrhythmias.
21094367 - Effect of implantable cardioverter-defibrillator on left ventricular ejection fraction ...
19954477 - Hemoperfusion with a polymyxin b fiber column decreases clotting activity.
3190487 - Discrepancies between serum and erythrocyte concentrations of vitamin e in hemodialysis...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  6     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1985 Oct 
Date Detail:
Created Date:  1985-10-24     Completed Date:  1985-10-24     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  814-21     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiodarone / therapeutic use*
Benzofurans / therapeutic use*
Electrocardiography
Electrophysiology
Female
Humans
Long-Term Care
Male
Middle Aged
Recurrence
Risk
Tachycardia / drug therapy*,  physiopathology
Grant Support
ID/Acronym/Agency:
HL-06308/HL/NHLBI NIH HHS; HL-07182/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Benzofurans; 1951-25-3/Amiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring i...
Next Document:  Effects of nitroglycerin-induced hypotension on myocardial blood flow in a two vessel occlusion-sten...